Position in GSK
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$841,235
+$237,788 QoQ
Shares Held
16,048
+46.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#380
of 1,033 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Texas Bank & Trust Co holds $17,417,326 across 10 Drug Manufacturers - General names. GSK ranks #7 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
18,940 | $4,810,191 | |
| 2 | LLY |
ELI LILLY & Co
|
3,359 | $4,028,884 | |
| 3 | MRK |
Merck & Co., Inc.
|
14,116 | $1,813,904 | |
| 4 | AZN |
Astrazeneca PLC
|
9,355 | $1,773,894 | |
| 5 | ABBV |
AbbVie Inc.
|
5,258 | $1,323,121 | |
| 6 | NVS |
Novartis AG
|
5,429 | $850,832 | |
| 7 | GSK |
GSK plc
This page
|
16,048 | $841,235 | |
| 8 | PFE |
Pfizer Inc
|
32,803 | $789,894 |
All Filings in GSK
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $841,235 | 16,048 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $603,447 | 10,934 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $744,328 | 15,178 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $469,537 | 10,879 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $257,241 | 6,699 | Shares | Sole | 2025-08-05 | |
| No filing history on record for this holder in this stock. | ||||||